<DOC>
	<DOCNO>NCT01780077</DOCNO>
	<brief_summary>The purpose trial evaluate safety tolerability multiple ( 3 ) intradermal dose RXI-109 small surgical incision abdominal skin healthy volunteer . The effect RXI-109 versus placebo scar incision site evaluate visually , histologically , biomarker analysis .</brief_summary>
	<brief_title>Evaluation Safety , PK , Preliminary Effects Scar Formation Multiple Intradermal Administrations RXI-109</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<criteria>Males female , 2150 year age General good health ; female pregnant lactate Phototype 3 base Fitzpatrick scale . Pregnant lactating Use tobacco nicotinecontaining product within 1 month prior enrollment study Type 1 2 diabetes mellitus A history presence medical condition therapy would make subject unsafe candidate opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Scar</keyword>
	<keyword>Scar prevention</keyword>
	<keyword>Fibrosis</keyword>
</DOC>